甲甲酸毒性的粘膜皮肤不良影响:一个案例系列
Bibek Subedi1, Sajana Bhandari2, Sunil Timilsina3
1Lotus Skin and Hair Clinic, Boudha, Kathmandu, Nepal.
JNMA; journal of the Nepal Medical Association
|July 14, 2025
概括
过度使用甲托雷克萨特可以引起严重的毒性,导致发烧,皮肤病变和异常血细胞计数. 早期识别和对正确剂量的患者教育对于预防不良反应和确保患者安全至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
- 毒理学 毒理学 毒理学
背景情况:
- 甲托雷克萨特是皮肤病学,风湿病学和瘤学中必不可少的药物.
- 与患者相关的因素,包括误解和试图加速缓解的尝试,有助于甲状腺素过度使用.
- 过度使用可能会导致严重甚至致命的毒性.
研究的目的:
- 提出一系列案例,详细说明因不适当剂量而导致的甲甲酸毒性.
- 要突出临床表现和管理策略的甲状腺毒性.
- 强调患者咨询有关甲状腺 administration. methotrexate 的重要性.
主要方法:
- 采用案例系列方法,分析了五种甲醇毒性实例.
- 审查了临床数据,包括症状,实验室参数和治疗结果.
- 管理方案包括停止使用甲状腺素,使用白素救援和支持性护理.
主要成果:
- 所有五名患者都出现了特征性症状:发烧,粘膜皮肤病变和血液学异常.
- 干预后,三名患者完全康复,症状消失,血液检查正常化.
- 两名患者经历了致命的结局,尽管治疗,强调毒性的严重性.
结论:
- 甲托雷克萨特毒性是与每日剂量和过度使用相关的重大风险.
- 迅速识别毒性症状和立即救援对于管理至关重要.
- 对正确的甲状腺素剂量进行全面的患者教育对于预防毒性和改善患者的治疗结果至关重要.
相关概念视频
Toxic Reactions: Overview
1.2K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.2K
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
385
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
385
Skin Diseases and Disorders
4.2K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
4.2K
Teratogenicity
2.8K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.8K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
272
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
272
Mutagenicity and Carcinogenicity
1.4K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K


